Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Partmann who wrote (764)	12/16/1999 10:51:00 AM
From: tewdwr	Read Replies (1) of 10345

Anyone care to offer insight into the value of the ISIP (ISIS Pharma)warrants, in return for a cash infusion from ELN, announced in May 99? ISIP blew up yesterday on failure of its Crohns disease ISIS-2302 compound. They also have a contract with ELN to develop an oral dosing formulation for large molecule ISIS-2302 and anti-sense compounds. Does anyone think either could substantially impact ELN's financials going forward, i.e.-lower earnings projections?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next